<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="159937">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02137694</url>
  </required_header>
  <id_info>
    <org_study_id>RB 13.161 PapU-APV</org_study_id>
    <nct_id>NCT02137694</nct_id>
  </id_info>
  <brief_title>Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer</brief_title>
  <acronym>PapU-APV</acronym>
  <official_title>Comparison of the Urinary and Vaginal Auto-takings for the Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Auto-takings by APU and vaginal APV during the consultations for FCU in the department of
      gynecology-obstetrics (Group 1) according to an instructions for use proposed to the
      inclusive women, with consent; the same proposal, APU and APV, is made for other
      consultations requiring a screening on the CHRU (Group 2: dermatology, endocrinology,
      ambulatory surgery, inner medicine, pneumology, oncology). Auto-takings transmitted in the
      laboratory of the CHRU of Brest for test HPV by quantitative real-time PCR. Results
      transmitted to the women and to the doctors of consultation. In case of positive test (15
      %), the patients are directed to a gynecologist. Confrontation with the cytological data
      when available (Group 1) .
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Research for human Papillomavirus by vaginal auto-takings and urinary test</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Estimate the research for human Papillomavirus ( HPV) in the vaginal auto-takings ( APV) and urinary ( APU) test at women from 25 to 65 years old requiring a screening.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The global logistic of the study</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Estimate the practicability, the organization of the screening, the follow-up of the women at the CHRU.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">460</enrollment>
  <condition>Research Human Papillomavirus ( HPV) by Vaginal Auto-takings ( APV) and Urinary Test</condition>
  <arm_group>
    <arm_group_label>PapU-APV</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>No drug and no placebo will be used in this study. For the study participants, only their medical history data and vaginal auto-takings ( APV) and urinary will be collected.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>vaginal auto-takings  and urinary test</intervention_name>
    <description>vaginal auto-takings  and urinary test</description>
    <arm_group_label>PapU-APV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All the 25-65-year-old women requiring a screening and seen in consultation of the
             departments targeted by the CHRU of Brest

        Exclusion Criteria:

          -  Women except age limit, refusal to participate, hysterectomy, pregnancy and
             post-therapeutic follow-up.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher PAYAN, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU Brest</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHRU de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Payan, PU-PH</last_name>
      <phone>2-98-14-51-01</phone>
      <phone_ext>+33</phone_ext>
      <email>christopher.payan@chu-brest.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>May 12, 2014</lastchanged_date>
  <firstreceived_date>April 30, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Papillomavirus</keyword>
  <keyword>Vaginal auto-takings</keyword>
  <keyword>Urinary test</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
